Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|92|5|283-290

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.5, 2017-02, pp. : 283-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interlaboratory concordance of PD‐L1 immunohistochemistry for non‐small‐cell lung cancer

By  

HISTOPATHOLOGY, Vol. 72, Iss. 3, 2018-02 ,pp. : 449-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post-Operative Rehabilitation for Surgically Resected Non-Small Cell Lung Cancer Patients: Serial Pulmonary Functional Analysis

By Sterzi Silvia   Cesario Alfredo   Cusumano Giacomo   Dall'Armi Valentina   Lapenna Luisa Maria   Cardaci Vittorio   Novellis Pierluigi   Lococo Filippo   Corbo Giuseppe Maria   Cafarotti Stefano   Margaritora Stefano   Granone Pierluigi  

Journal of Rehabilitation Medicine, Vol. 45, Iss. 9, 2013-10 ,pp. : 911-915

Medical Journals Limited

Access to resources Recommend Favorite

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 271-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use and impact of adjuvant chemotherapy in patients with resected non‐small cell lung cancer

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 1939-1947

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite